Romania Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports Market Reports Online XML Feed

Free Business Tech Map Get the technology blueprint + discover the 4-part/12-month process that I used to build a raving fan base that buys over $250k of my stuff... per year! From our sponsors

Romania Pharmaceuticals and Healthcare Report Q4 2013 Sep 18th 2013, 00:00 Price: $ 1295   BMI View: We forecast continued growth in Romania's pharmaceutical market due to greater private contributions to the cost of healthcare and a return to slight economic growth in 2013. The partial removal of elements of the claw-back tax will undoubtedly provide the industry with a slight boost this year, as will pressure from creditors to repay debts and companies on time. However, the delaying of changes to the reimbursement list until January 2014 will moderate the growth of patented and prescription medicines in 2013. These issues continue to weigh down BMI's assessment of Romania's Pharmaceutical and Healthcare Risk/Reward ratings. Headline Expenditure Projections ? Pharmaceuticals: RON13.55bn (US$3.91bn) in 2012 to RON13.96bn (US$4.29bn) in 2013; +3.0% in local currency terms and ... Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/274383.html

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions